+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 1
Age: 18Years +
All Genders
ID06641609

Evaluating Safety, Dosage, and Antitumor Effects of CFT8919 Capsules in Advanced Non-Small Cell Lung Cancer With EGFR Mutations

Led by Betta Pharmaceuticals Co., Ltd. · Updated on 2026-09-04

166

Participants Needed

1

Research Sites

26 weeks

Total Duration

AI-Summary

What This Trial Is About

This clinical trial focuses on patients with locally advanced or metastatic non-small cell lung cancer NSCLC who have mutations in the EGFR gene. The study aims to evaluate the safety, tolerability, how the body processes the drug pharmacokinetics, and the antitumor activity of CFT8919 capsules. Key questions include finding the maximum tolerated dose MTD of CFT8919 and determining if it shows antitumor effects in these patients. The study is divided into three parts dose-escalation, dose-expansion, and cohort-expansion phases. In the dose-escalation phase, participants receive increasing doses of CFT8919 capsules starting from 150 mg twice daily up to 900 mg twice daily to find the maximum tolerated dose. After this, participants receive the recommended phase II dose RP2D in the dose-expansion phase. In the cohort-expansion phase, patients with specific EGFR mutations, including resistant mutations following prior treatments, receive the RP2D to assess efficacy and safety. Participants will take CFT8919 capsules at assigned doses and undergo regular assessments including safety monitoring, pharmacokinetic testing, and tumor response evaluations. Researchers will measure outcomes like objective response rate, disease control rate, and progression-free survival. Blood and optionally tissue samples may be collected for biomarker research. Participation includes ongoing monitoring throughout treatment and follow-up lasting up to about two years for some measures.

CONDITIONS

Brief Title

A Phase I Study of CFT8919 in Patients With Advanced NSCLC

Research Team

Y

yun fan, PHD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here